<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn>
  <p>Institutional review board statement: The study was reviewed and approved by the Medical Ethics Review Committee of Harbin Medical University Cancer Hospital. </p>
 </fn>
 <fn>
  <p>Clinical trial registration statement: This registration policy applies to prospective, randomized, controlled trials only. </p>
 </fn>
 <fn>
  <p>Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment. </p>
 </fn>
 <fn fn-type="COI-statement">
  <p>Conflict-of-interest statement: The authors declare no competing interests.</p>
 </fn>
 <fn>
  <p>CONSORT 2010 Statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.</p>
 </fn>
 <fn>
  <p>Manuscript source: Unsolicited manuscript</p>
 </fn>
 <fn>
  <p>Peer-review started: November 3, 2020</p>
 </fn>
 <fn>
  <p>First decision: November 20, 2020</p>
 </fn>
 <fn>
  <p>Article in press: December 10, 2020</p>
 </fn>
 <fn>
  <p>Specialty type: Medicine, research and experimental</p>
 </fn>
 <fn>
  <p>Country/Territory of origin: China</p>
 </fn>
 <fn>
  <p>Peer-review report's scientific quality classification</p>
 </fn>
 <fn>
  <p>Grade A (Excellent): A</p>
 </fn>
 <fn>
  <p>Grade B (Very good): B, B</p>
 </fn>
 <fn>
  <p>Grade C (Good): 0</p>
 </fn>
 <fn>
  <p>Grade D (Fair): 0</p>
 </fn>
 <fn>
  <p>Grade E (Poor): 0</p>
 </fn>
 <fn>
  <p>P-Reviewer: Faloppi L, Otto G, Raisch K S-Editor: Fan JR L-Editor: Filipodia P-Editor: Yuan YY</p>
 </fn>
</fn-group>
